A--To Expand the Workscope of the PACT III Program

Scope

The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by reintroducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.

Documents, amendments and submission instructions are on the agency's own posting.